Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 0615-8219

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 0615-8219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxybutynin Chloride Extended-release Tablet (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 1)

FDA Label Image

Oxybutynin Chloride Extended Release Tablets (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 2)

FDA Label Image

Oxybutynin Chloride Extended Release Tablets (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 3)

FDA Label Image

Oxybutynin Chloride Er Tablets (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 4)

This is a report summarizing the results of a study on the effectiveness of Oxybutynin chloride extended-release tablets versus a placebo for treating urge urinary incontinence. The study measured the number of episodes of urge urinary incontinence per week and found that the Oxybutynin chloride extended-release tablets produced a statistically significant reduction compared to the placebo. The report includes mean change from baseline values and confidence intervals for the difference. There are also details about covariate adjustments for missing observations set to baseline values.*

FDA Label Image

Oxybutynin Chloride Er Tablets (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 5)

This is a report of a study on the efficacy of oxybutynin chloride extended-release tablets. The report provides statistical data comparing Oxybutynin chloride to a placebo. The report also provides information on the difference between oxybutynin chloride extended-release tablets and oxybutynin fluid for comparable efficacy, and gives the mean changes from baseline in episodes per week.*

FDA Label Image

Oxybutynin Chloride Er 5mg Tabs Bingo Card Label (Oxybutynin Chloride Er Tabs 5mg 10mg Zyduscadila 6)

This text seems to be a label from a medication package. It contains warnings and instructions for storage and use, as well as information on the medication itself, such as its name, strength, lot number, and expiration date. However, there are some inconsistencies and unclear characters, making it difficult to fully understand the information provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.